Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors

Summary

The purpose of this study is to determine whether the combination of Ulocuplumab and Nivolumab is safe and effective in the treatment of pancreatic cancer and small cell lung cancer.

Timeline

Start

2015-07-13

Primary completion

2017-01-27

Completion

2017-01-27

Outcome

Outcome not reported

Stopped: “Trial terminated because of lack of efficacy in the short term acute phase”

Drugs

Indications